These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7877530)

  • 1. Arginine supplementation in the prevention and treatment of osteoporosis.
    Visser JJ; Hoekman K
    Med Hypotheses; 1994 Nov; 43(5):339-42. PubMed ID: 7877530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-arginine, the natural precursor of NO, is not effective for preventing bone loss in postmenopausal women.
    Baecker N; Boese A; Schoenau E; Gerzer R; Heer M
    J Bone Miner Res; 2005 Mar; 20(3):471-9. PubMed ID: 15746992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Role of L-Arginine and Vitamin E Against Bone Loss Induced by Nano-Zinc Oxide in Rats.
    Abdelkarem HM; Fadda LH; El-Sayed EM; Radwan OK
    J Diet Suppl; 2018 May; 15(3):300-310. PubMed ID: 28759296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
    Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of growth hormone (GH) and GH secretagogues for bone mass and density.
    Svensson J
    Curr Pharm Des; 2002; 8(23):2023-32. PubMed ID: 12171516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone (GH) and adult bone remodeling: the potential use of GH in treatment of osteoporosis.
    Brixen K; Kassem M; Eriksen EF; Nielsen HK; Flyvbjerg A; Mosekilde L
    J Pediatr Endocrinol; 1993; 6(1):65-71. PubMed ID: 8374692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis and the growth hormone-insulin-like growth factor axis.
    Geusens PP; Boonen S
    Horm Res; 2002; 58 Suppl 3():49-55. PubMed ID: 12435898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone temporal effects on bone formation and resorption.
    Kroll MH
    Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
    Kassem M; Brixen K; Blum WF; Mosekilde L; Eriksen EF
    J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between alkaline phosphatase and bone alkaline phosphatase activity and the growth hormone/insulin-like growth factor-1 axis and vitamin D status in children with growth hormone deficiency.
    Witkowska-Sędek E; Stelmaszczyk-Emmel A; Majcher A; Demkow U; Pyrżak B
    Acta Biochim Pol; 2018; 65(2):269-275. PubMed ID: 29649340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-arginine does not improve biochemical and hormonal response in trained runners after 4 weeks of supplementation.
    Alvares TS; Conte-Junior CA; Silva JT; Paschoalin VM
    Nutr Res; 2014 Jan; 34(1):31-9. PubMed ID: 24418244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory effects of l-arginine and soy enriched diet on bone homeostasis abnormalities in streptozotocin-induced diabetic rats.
    El-Maraghy SA; Mehana NA
    Chem Biol Interact; 2015 Mar; 229():9-16. PubMed ID: 25617479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study.
    Brixen K; Kassem M; Nielsen HK; Loft AG; Flyvbjerg A; Mosekilde L
    J Bone Miner Res; 1995 Dec; 10(12):1865-74. PubMed ID: 8619366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine and ornithine supplementation increases growth hormone and insulin-like growth factor-1 serum levels after heavy-resistance exercise in strength-trained athletes.
    Zajac A; Poprzecki S; Zebrowska A; Chalimoniuk M; Langfort J
    J Strength Cond Res; 2010 Apr; 24(4):1082-90. PubMed ID: 20300016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acute effects of a low and high dose of oral L-arginine supplementation in young active males at rest.
    Forbes SC; Bell GJ
    Appl Physiol Nutr Metab; 2011 Jun; 36(3):405-11. PubMed ID: 21574873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New drugs with positive effects on bones].
    Zofková I; Kanceva RL
    Cas Lek Cesk; 1997 Jul; 136(15):459-63. PubMed ID: 9340191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Cellular mechanism and etiology of osteoporosis].
    Koga T; Takayanagi H
    Clin Calcium; 2015 Sep; 25(9):1293-300. PubMed ID: 26320528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral arginine-lysine does not increase growth hormone or insulin-like growth factor-I in old men.
    Corpas E; Blackman MR; Roberson R; Scholfield D; Harman SM
    J Gerontol; 1993 Jul; 48(4):M128-33. PubMed ID: 8315224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacologic therapy of osteoporosis].
    Kushida K
    Nihon Rinsho; 1994 Sep; 52(9):2367-77. PubMed ID: 7967083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy.
    Milliken LA; Going SB; Houtkooper LB; Flint-Wagner HG; Figueroa A; Metcalfe LL; Blew RM; Sharp SC; Lohman TG
    Calcif Tissue Int; 2003 Apr; 72(4):478-84. PubMed ID: 12574871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.